277 related articles for article (PubMed ID: 477052)
1. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
[TBL] [Abstract][Full Text] [Related]
2. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
Boukari M; Rottembourg J; Jaudon MC; Clavel JP; Legrain M; Galli A
Nouv Presse Med; 1978 Jan; 7(2):85-8. PubMed ID: 349501
[TBL] [Abstract][Full Text] [Related]
3. In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring.
Fenwick S; Roberts EA; Mahesh BS; Roberts NB
Ann Clin Biochem; 2005 Mar; 42(Pt 2):149-52. PubMed ID: 15829127
[TBL] [Abstract][Full Text] [Related]
4. [The trace elements zinc and copper in chronic renal failure].
Prehn B
Z Urol Nephrol; 1988 Jan; 81(1):35-42. PubMed ID: 3364046
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the plasma aluminum concentration of hemodialysis patients].
Kuleva V; Petrov I; Antonov S; Kiriakov Z
Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
[TBL] [Abstract][Full Text] [Related]
8. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
Sárszegi Z; Jobst K; Nagy J
Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
[TBL] [Abstract][Full Text] [Related]
9. What is the value of plasma/serum aluminum in patients with chronic renal failure?
Winney RJ; Cowie JF; Robson JS
Clin Nephrol; 1985; 24 Suppl 1():S2-8. PubMed ID: 3842104
[TBL] [Abstract][Full Text] [Related]
10. Differences in plasma and tissue aluminum concentrations due to different aluminum-containing drugs in patients with renal insufficiency and with normal renal function.
Winterberg B; Bertram H; Rolf N; Roedig M; Kisters K; Remmers S; Spieker C; Zumkley H
J Trace Elem Electrolytes Health Dis; 1987 Dec; 1(2):69-72. PubMed ID: 2856571
[TBL] [Abstract][Full Text] [Related]
11. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
12. Aluminium load in patients with analgesic nephropathy.
Schwarz A; Kraft D; Keller F; Gawlik D; Offermann G
Miner Electrolyte Metab; 1987; 13(3):141-6. PubMed ID: 3627045
[TBL] [Abstract][Full Text] [Related]
13. Copper, zinc, calcium and magnesium in chronic renal failure.
Avasthi G; Singh HP; Katyal JC; Avasthi R; Aggarwal SP
J Assoc Physicians India; 1991 Jul; 39(7):531-4. PubMed ID: 1800497
[TBL] [Abstract][Full Text] [Related]
14. [Plasma and intra-erythrocytic concentrations of copper and zinc in uremic patients treated by periodic hemodialysis].
Agenet C; Brugère CC; Reynier JP
Ann Biol Clin (Paris); 1989; 47(8):493-6. PubMed ID: 2690680
[TBL] [Abstract][Full Text] [Related]
15. [Aluminum poisoning caused by the phosphate binder in a non-dialysed child with chronic renal insufficiency].
Feldmann B; Färber D; Pontz BF
Radiologe; 1992 Jul; 32(7):327-32. PubMed ID: 1509030
[TBL] [Abstract][Full Text] [Related]
16. [The natural history of dialysis encephalopathy (author's transl)].
Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
[TBL] [Abstract][Full Text] [Related]
17. Plasma aluminium: a redundant test for patients on dialysis?
Gault PM; Allen KR; Newton KE
Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
[TBL] [Abstract][Full Text] [Related]
18. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
Graf H; Stummvoll HK; Meisinger V
Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
[TBL] [Abstract][Full Text] [Related]
19. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.
Wallace MR; Pybus J
N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451
[TBL] [Abstract][Full Text] [Related]
20. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
Breuer J; Moniz C; Baldwin D; Parsons V
Nephrol Dial Transplant; 1987; 2(5):347-50. PubMed ID: 3122112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
